Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Hematopoiesis01:20

Overview of Hematopoiesis

6.0K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
6.0K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

614
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
614
Documentation in Long-Term and Home Healthcare Setting01:29

Documentation in Long-Term and Home Healthcare Setting

1.3K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
1.3K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.6K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.6K
Hematopoiesis01:21

Hematopoiesis

7.5K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
7.5K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

2.3K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CAR T Cell Therapy as a Definitive Consolidation for Older Adults with B-ALL in First Complete Remission.

Blood advances·2026
Same author

Implementing CHARM in Transplant Practice.

Blood advances·2026
Same author

Treatment of Multiple Myeloma: ASCO Living Guideline, Version 2026.1.1.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Eligibility versus appropriateness in allogeneic HCT.

Blood advances·2026
Same author

Disability-Free Survival: A Novel Morbidity Endpoint for Older Adult Allogeneic Hematopoietic Cell Transplantation.

Transplantation and cellular therapy·2026
Same author

Nonmyeloablative conditioning combined with the anti-CD117 antibody briquilimab in older adults with high-risk AML and MDS.

Blood·2026

Related Experiment Video

Updated: Nov 6, 2025

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

29.9K

Characterize, Optimize, and Harmonize: Caring for Older Adults With Hematologic Malignancies.

Tanya M Wildes1, Andrew S Artz2

  • 1Cancer & Aging Research Group, St. Louis, MO.

American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|May 12, 2021
PubMed
Summary

Geriatric assessments are crucial for older adults with hematologic malignancies, optimizing treatment through resilience evaluation and patient goals. This approach improves outcomes and reduces mortality in stem cell transplant recipients.

More Related Videos

Homing of Hematopoietic Cells to the Bone Marrow
10:40

Homing of Hematopoietic Cells to the Bone Marrow

Published on: March 18, 2009

29.7K
Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

11.9K

Related Experiment Videos

Last Updated: Nov 6, 2025

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

29.9K
Homing of Hematopoietic Cells to the Bone Marrow
10:40

Homing of Hematopoietic Cells to the Bone Marrow

Published on: March 18, 2009

29.7K
Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

11.9K

Area of Science:

  • Geriatric Medicine
  • Hematology
  • Oncology

Background:

  • The aging population is increasing the incidence of hematologic malignancies in older adults.
  • Allogeneic stem cell transplant is expanding to older age groups but carries significant risks.
  • Current risk assessments may not fully capture age-related vulnerabilities.

Purpose of the Study:

  • To highlight the importance of geriatric-focused evaluations for older adults undergoing stem cell transplant.
  • To propose a structured approach for optimizing resilience in elderly patients.
  • To emphasize personalized treatment strategies for older adults with hematologic malignancies, particularly myeloma.

Main Methods:

  • Implementing a three-step approach: characterize resiliency, bolster resilience, and harmonize with patient goals.
  • Utilizing geriatric assessments to identify vulnerabilities beyond performance status and comorbidities.
  • Incorporating frailty assessments, such as the International Myeloma Working Group frailty scale, for myeloma patients.

Main Results:

  • Emerging data indicate this geriatric-focused approach is linked to reduced nonrelapse mortality.
  • Shorter hospital length of stay and improved survival rates post-transplant have been observed.
  • Frailty assessment enables more personalized toxicity risk estimation in myeloma treatment.

Conclusions:

  • Geriatric assessment is vital for improving the safety and efficacy of stem cell transplantation in older adults.
  • Personalized care, considering resilience and patient goals, is key for managing hematologic malignancies in the elderly.
  • Comprehensive care for older adults with myeloma should address frailty, polypharmacy, cognition, and falls.